Skip to main content

Table 2 Patient condition at the time of diagnosis

From: Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms

Variable

Patient group (n = 27)

Rate (%)

X ± SE

Tumour grading

  

 G1

26

96.3

 G2

1

3.7

CgA (ng/ml)

  

215.19 ± 53.63

 > 100

10

55.6 (n = 18)

 < 100

8

44.4 (n = 18)

 Unknown

9

Gastrin (pg/ml)

  

796.48 ± 99.47

 > 100

27

100

 < 100

0

0